Hemorrhagic Occlusive Retinal Vasculitis and Intravitreal Anti-VEGF

JAMA Ophthalmology 2026

View at publisher
Authors: Prithvi Ramtohul, Mathieu Chanal, Thierry David
DOI: 10.1001/jamaophthalmol.2026.0538
Cited by: 1
References: 5

Abstract

This case report discusses bilateral vision loss 2 weeks after second bilateral intravitreal injection of the anti–vascular endothelial growth factor (VEGF) brolucizumab for diabetic macular edema in a woman in her 60s.

Fields of Study & Subjects

Retinal Diseases and Treatments Ocular Diseases and Behçet’s Syndrome Retinal and Optic Conditions

Publication details

Journal / source
JAMA Ophthalmology
Publisher
American Medical Association (AMA)
Volume
144
Issue
5
Pages
486–486
Publication date
2 April 2026
Language
EN